Cell cycle progression is negatively regulated by the pocket proteins pRb, p107, and p130. However, the mechanisms responsible for this inhibition are not fully understood. Here, we show that overexpression of p107 in fibroblasts inhibits Cdk2 activation and delays S phase entry. The inhibition of Cdk2 activity is correlated with the accumulation of p27, consequent to a decreased degradation of the protein, with no change of Thr187 phosphorylation. Instead, we observed a marked decrease in the abundance of the F-box receptor Skp2 in p107-overexpressing cells. Reciprocally, Skp2 accumulates to higher levels in p107−/− embryonic fibroblasts. Ectopic expression of Skp2 restores p27 down-regulation and DNA synthesis to the levels observed in parental cells, whereas inactivation of Skp2 abrogates the inhibitory effect of p107 on S phase entry. We further show that the serum-dependent increase in Skp2 half-life observed during G1 progression is impaired in cells overexpressing p107. We propose that p107, in addition to its interaction with E2F, inhibits cell proliferation through the control of Skp2 expression and the resulting stabilization of p27.
Skip Nav Destination
Article navigation
3 January 2005
Article|
January 03 2005
p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2
Geneviève Rodier,
Geneviève Rodier
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Search for other works by this author on:
Constantin Makris,
Constantin Makris
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
2Department of Pharmacology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Search for other works by this author on:
Philippe Coulombe,
Philippe Coulombe
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
3Department of Molecular Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Search for other works by this author on:
Anthony Scime,
Anthony Scime
4Ottawa Health Research Institute, Ottawa, Ontario K1Y 4E9, Canada
Search for other works by this author on:
Keiko Nakayama,
Keiko Nakayama
5Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
Search for other works by this author on:
Keiichi I. Nakayama,
Keiichi I. Nakayama
5Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
Search for other works by this author on:
Sylvain Meloche
Sylvain Meloche
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
2Department of Pharmacology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
3Department of Molecular Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Search for other works by this author on:
Geneviève Rodier
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Constantin Makris
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
2Department of Pharmacology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Philippe Coulombe
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
3Department of Molecular Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Anthony Scime
4Ottawa Health Research Institute, Ottawa, Ontario K1Y 4E9, Canada
Keiko Nakayama
5Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
Keiichi I. Nakayama
5Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
Sylvain Meloche
1Institut de recherche en immunovirologie et cancérologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
2Department of Pharmacology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
3Department of Molecular Biology, Université de Montréal, Montreal, Quebec H3C 3J7, Canada
Correspondence to Sylvain Meloche: [email protected]
Constantin Makris's present address is Merck Frosst Center for Therapeutic Research, Kirkland, Quebec H9H 3L1, Canada.
Abbreviations used in this paper: APC/C, anaphase-promoting complex/cyclosome; MEF, mouse embryonic fibroblast; siRNA, small interfering RNA.
Received:
April 26 2004
Accepted:
November 09 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2005
J Cell Biol (2005) 168 (1): 55–66.
Article history
Received:
April 26 2004
Accepted:
November 09 2004
Citation
Geneviève Rodier, Constantin Makris, Philippe Coulombe, Anthony Scime, Keiko Nakayama, Keiichi I. Nakayama, Sylvain Meloche; p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2 . J Cell Biol 3 January 2005; 168 (1): 55–66. doi: https://doi.org/10.1083/jcb.200404146
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement